Abstract:Diet and the gut microbiota have a profound influence on physiology and health, however, mechanisms are still emerging. Here we outline several pathways that gut microbiota products, particularly short-chain fatty acids (SCFAs), use to maintain gut and immune homeostasis. Dietary fibre is fermented by the gut microbiota in the colon, and large quantities of SCFAs such as acetate, propionate, and butyrate are produced. Dietary fibre and SCFAs enhance epithelial integrity and thereby limit systemic endotoxemia. Moreover, SCFAs inhibit histone deacetylases (HDAC), and thereby affect gene transcription. SCFAs also bind to 'metabolite-sensing' G-protein coupled receptors (GPCRs) such as GPR43, which promotes immune homeostasis. The enormous amounts of SCFAs produced in the colon are sufficient to lower pH, which affects the function of proton sensors such as GPR65 expressed on the gut epithelium and immune cells. GPR65 is an anti-inflammatory Gαs-coupled receptor, which leads to the inhibition of inflammatory cytokines. The importance of GPR65 in inflammatory diseases is underscored by genetics associated with the missense variant I231L (rs3742704), which is associated with human inflammatory bowel disease, atopic dermatitis, and asthma. There is enormous scope to manipulate these pathways using specialized diets that release very high amounts of specific SCFAs in the gut, and we believe that therapies that rely on chemically modified foods is a promising approach. Such an approach includes high SCFA-producing diets, which we have shown to decrease numerous inflammatory western diseases in mouse models. These diets operate at many levels - increased gut integrity, changes to the gut microbiome, and promotion of immune homeostasis, which represents a new and highly promising way to prevent or treat human disease.

Worldwide practices for pharmacologic therapy in esophageal variceal hemorrhage

Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity

Regulation of short-chain fatty acids in the immune system

Short-chain fatty acids: linking diet, the microbiome and immunity

Regulation of immune cell function by short-chain fatty acids

Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy

Dietary fiber and SCFAs in the regulation of mucosal immunity

Short‐chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells

SCFA: mechanisms and functional importance in the gut

Mycoplasma gallisepticum: Influence of cell invasiveness on the outcome of experimental infection in chickens.

A major mechanism for immunomodulation: Dietary fibres and acid metabolites

The emerging role of microbiota-derived short-chain fatty acids in immunometabolism

Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections

B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids

Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis

The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective

Short chain fatty acids regulate T cell metabolism to promote IL-22 production and gut immunity

Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases

An expanding stage for commensal microbes in host immune regulation

The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease

Gut Microbial Metabolites on Host Immune Responses in Health and Disease